Health care system across the world have been very expensive for specialised diseases. And, the resources required for a new drug research are not easily available in many countries. The big pharma companies are busy selling drugs that are expensive to the consumers rather than generic drugs, that are affordable and efficient. Considering the example of Ebola, which is a serious medical condition, many countries have decided to invest in the research and development of drugs.
The research and the investment are continuously going on to find the cure for the deadly diseases. There is a need for new technology integration which will automate the value-based pricing and usage of real-world data.
DIGIPHARM is creating solutions for the healthcare system by developing the value-based health care delivery system. They have understood the basic concept behind the health care system. The first pillar is the incentivisation and if the proper reimburse is provided to the concerned link of the healthcare chain that the process will be smooth.
To complete this aspect of healthcare delivery, they have designed a reimburse platform which works on the blockchain technology and Smart Contracts. It will accelerate integration, coordination and delivery of a health care system, which focus on the patients and not on the insurance companies. This will allow the manufacturers to utilise the patient's medical details to offer more personalised services. Based on the smart contracts, pricing agreement is signed between the patients and the manufacturers.
Digipharms’ vision is to be ‘the pioneer of value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry’ using revolutionary blockchain technology.
Digipharm aims to utilize innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivize innovation and expedite the transformation to personalized healthcare
Digipharms aims to accelerate the restructuring of the delivery of healthcare services that the system desperately needs to a value-based approach. The current shortage of the global health infrastructure results in substantial inefficiencies, wasted and least optimal health outcomes important stakeholders, patient.
In the field of health today, there is a lack of incentives for health systems and service providers to focus on mutually beneficial collaboration and maximization of patient vision results.
Digipharm aims to leverage innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and ignore the limitations of infrastructure to drive value enhancement, incentivize innovation and accelerate the transformation to personalized health services.
You may wonder how Digipharm can be so sophisticated in facilitating the patients to be healthy. One of the key points is due to the application of Blockchain. Yes, Blockchain is now not only to support financial systems but also the others including the health system. The basic principle of Blockchain is that this system doesn’t include the third party during all the business and transaction. That’s why; all the process tends to be simpler, easier, and faster. It is so good in the world of health care in which the patients must need to be taken care of as soon as possible.
The Reimburse platform harnesses the benefits of automated ‘smart contracts’ and blockchain technology; facilitating the application of truly dynamic innovative pricing solutions between healthcare systems and manufacturers, in a secure and compliant fashion with minimal administrative burden. Use of the Reimburse platform will expedite integration, coordination and delivery of patient centric healthcare systems with a focus on improving patient outcomes while accelerating ‘payment for value‘ mechanisms between payers and manufacturers using neutrally-enforceable agreements in a peer to peer fashion.
The Insights platform will extract anonymised patient level data from the Reimburse platform and health information systems to the world’s first ‘live’ RWE database. Insights will provide a symbiotic solution with Reimburse to complement the progressive transformation towards value-based healthcare delivery systems. The development of a ‘live’ evidence repository will allow the integration of knowledge back into the delivery system in real time to facilitate decision making, drug development and health related research. Patients will be incentivised to contribute their health information to the Insights platform and will gain access to valuable health information that is currently unattainable.
Digipharm (DPH) tokens will be used to pay license fees / access on the Digipharm platform. Access fees will always be determined and fixed in USD value and the number of tokens required will depend on the type of access (producer, patient, payer or provider) combined with the necessary interaction form. The quantity of tokens required for such interactions may change, relative to the market value of the DPH.
Token Name: DPH
Total Supply: 100,000,000
Fixed (ERC-20)
Decimal: 18
Pre - Sale: 15,000,000 DPH
Base Price: 1.00 USD
Pre - Sale Length: 4 Weeks
Pre - Sale Discount: 35%
Main Sale: 50,000,000 DPH
Week 1: 25% Frozen 25 million token
Week 2: 15% Frozen 15 million token
Week 3: 10% Frozen 10 million token
Week 4: 1.00 USD
Ahmed Abdulla - Founder/CEO
Girisha Fernando - Co-Founder/COO
Zach Daniels - CTO
Ralf Gerteis - Commercial Strategy
Alexander Sverdlov - Cybersecurity Strategy
Meredith Darden - Digital Marketing Lead
Alexey Popov - Web Development
Michael Gubert - UI/UX Design
Leon Rebolledo - Integration Lead
Rolf Günter - Legal Counsel
Bobby Kaura - Business Developmen
Dr. Mohamed Abdulla - Clinical Transformation
Dr. Hasham Al-Meshhedani - Patient Engagement
Ali Al-Sudani - Clinical Pharmacist
Dr. Rami Radwan - Clinical Relations
Peter Sandbach - Communications Director
Marko Granic - Graphic Designer
Sven Möller - ICO Advisor, Swisscom Blockchain AG
Kamal Youssefi - Enterprise Blockchain Advisor, Swisscom Blockchain AG
Waldemar Scherer - Life Sciences Blockchain Advisor, wisscom Blockchain AG
Sam Mantle - Health & Life Sciences Technology, Advisor
Daniel Heller - PR Advisor, Partner Farner Consulting AG
Claudio Staub - Co-Head Startup Communications, Farner Consulting AG
Anas Aman - Quality and Testing, IBM
Lloyd Jefferies - CRM Advisor, KPMG
Per-Olof Thuresson - Health Economist, Roche
Fadi Chehadah - Health Economist, NICE UK
Website: https://www.digipharm.ch/
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Telegram: https://t.me/digipharm
Facebook: https://www.facebook.com/digipharmteam/
Twitter: https://twitter.com/DigipharmTeam
My Profile Link: https://bitcointalk.org/index.php?action=profile;u=919492
